AAE-C1-INH deficiency is an uncommon but well-recognized clinical entity, with an estimated prevalence of approximately one in 100000 people and accounting for fewer than 10% of all C1-INH deficiencies [1,2]. This evidence concerns the gene SERPING1 and hyperinsulinemic hypoglycemia, familial, 4.